- Home
- ANGH vs RADX Comparison
ANGH vs RADX Comparison
Compare ANGH & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGH
- RADX
- Stock Information
- Founded
- ANGH 2012
- RADX 2021
- Country
- ANGH United Arab Emirates
- RADX Australia
- Employees
- ANGH N/A
- RADX N/A
- Industry
- ANGH Telecommunications Equipment
- RADX
- Sector
- ANGH Consumer Discretionary
- RADX
- Exchange
- ANGH Nasdaq
- RADX NYSE
- Market Cap
- ANGH 32.1M
- RADX 32.5M
- IPO Year
- ANGH N/A
- RADX N/A
- Fundamental
- Price
- ANGH $0.49
- RADX $4.05
- Analyst Decision
- ANGH
- RADX Strong Buy
- Analyst Count
- ANGH 0
- RADX 2
- Target Price
- ANGH N/A
- RADX $13.50
- AVG Volume (30 Days)
- ANGH 12.7K
- RADX 22.6K
- Earning Date
- ANGH 07-15-2025
- RADX 02-26-2025
- Dividend Yield
- ANGH N/A
- RADX N/A
- EPS Growth
- ANGH N/A
- RADX N/A
- EPS
- ANGH N/A
- RADX N/A
- Revenue
- ANGH $78,093,405.00
- RADX $204,609.00
- Revenue This Year
- ANGH N/A
- RADX N/A
- Revenue Next Year
- ANGH N/A
- RADX N/A
- P/E Ratio
- ANGH N/A
- RADX N/A
- Revenue Growth
- ANGH 88.72
- RADX N/A
- 52 Week Low
- ANGH $0.42
- RADX $3.50
- 52 Week High
- ANGH $1.08
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- ANGH 44.59
- RADX N/A
- Support Level
- ANGH $0.47
- RADX N/A
- Resistance Level
- ANGH $0.52
- RADX N/A
- Average True Range (ATR)
- ANGH 0.02
- RADX 0.00
- MACD
- ANGH 0.00
- RADX 0.00
- Stochastic Oscillator
- ANGH 39.80
- RADX 0.00
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.